Polaris Group (TPE:6550)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.50
0.00 (0.00%)
Apr 28, 2026, 1:30 PM CST
-53.27%
Market Cap 15.05B
Revenue (ttm) 40.60M
Net Income (ttm) -3.93B
Shares Out 859.89M
EPS (ttm) -5.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 527,896
Average Volume 1,281,942
Open 17.75
Previous Close 17.50
Day's Range 17.20 - 17.75
52-Week Range 16.50 - 46.50
Beta 0.82
RSI 33.26
Earnings Date May 14, 2026

About Polaris Group

Polaris Group, together with its subsidiaries, offers biotechnology, pharmaceutical testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It also offers healthcare consulting, staffing, and MDS solutions. The company was incorporated in 2006 and is based in Grand Cayman, Cayman Islands. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 165
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6550
Full Company Profile

Financial Performance

In 2025, Polaris Group's revenue was 40.60 million, a decrease of -62.05% compared to the previous year's 107.00 million. Losses were -3.93 billion, 56.9% more than in 2024.

Financial Statements

News

There is no news available yet.